Group One Trading, L.P. Ocular Therapeutix, Inc Transaction History

Group One Trading, L.P.

$3.01 Billion
Q2 2024

A detailed history of Group One Trading, L.P. transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Group One Trading, L.P. holds 40,725 shares of OCUL stock, worth $446,346. This represents 0.01% of its overall portfolio holdings.

Number of Shares

40,725

Previous 373,303 89.09%

Holding current value

$446,346

Previous $3.4 Million 91.82%

% of portfolio

0.01%

Previous 0.13%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$4.2 - $8.69 $1.4 Million - $2.89 Million	-332,578 Reduced 89.09%	40,725 $278,000
Q1 2024 May 10, 2024	BUY	$3.85 - $10.93 $1.27 Million - $3.59 Million	328,904 Added 740.79%	373,303 $3.4 Million
Q4 2023 Feb 14, 2024	BUY	$2.08 - $4.52 $75,127 - $163,257	36,119 Added 436.22%	44,399 $198,000
Q3 2023 Nov 09, 2023	BUY	$3.14 - $5.04 $25,999 - $41,731	8,280 New	8,280 $25,000
Q1 2023 May 12, 2023	BUY	$2.79 - $6.27 $49,522 - $111,292	17,750 Added 80.71%	39,742 $209,000
Q4 2022 Feb 09, 2023	SELL	$2.61 - $4.41 $40,969 - $69,223	-15,697 Reduced 41.65%	21,992 $61,000
Q3 2022 Nov 09, 2022	BUY	$4.09 - $6.5 $105,190 - $167,173	25,719 Added 214.86%	37,689 $156,000
Q2 2022 Aug 11, 2022	BUY	$3.01 - $5.22 $32,845 - $56,960	10,912 Added 1031.38%	11,970 $48,000
Q1 2022 May 12, 2022	BUY	$4.83 - $7.35 $5,110 - $7,776	1,058 New	1,058 $5,000
Q4 2021 Feb 11, 2022	SELL	$6.16 - $12.07 $261,769 - $512,914	-42,495 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$9.7 - $14.34 $390,250 - $576,926	-40,232 Reduced 48.63%	42,495 $425,000
Q2 2021 Aug 10, 2021	BUY	$13.43 - $19.16 $430,458 - $614,116	32,052 Added 63.25%	82,727 $1.17 Million
Q1 2021 May 12, 2021	SELL	$15.82 - $22.11 $201,799 - $282,035	-12,756 Reduced 20.11%	50,675 $832,000
Q4 2020 Feb 10, 2021	BUY	$7.91 - $22.95 $374,997 - $1.09 Million	47,408 Added 295.87%	63,431 $1.31 Million
Q3 2020 Nov 12, 2020	BUY	$7.36 - $9.87 $117,929 - $158,147	16,023 New	16,023 $122,000
Q4 2019 Feb 10, 2020	SELL	$2.57 - $4.73 $12,610 - $23,210	-4,907 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$3.04 - $5.32 $14,917 - $26,105	4,907 New	4,907 $15,000
Q1 2019 May 13, 2019	SELL	$3.51 - $4.77 $38,002 - $51,644	-10,827 Closed	0 $0
Q4 2018 Feb 06, 2019	SELL	$3.87 - $7.11 $26,103 - $47,956	-6,745 Reduced 38.38%	10,827 $43,000
Q3 2018 Nov 08, 2018	BUY	$5.42 - $6.99 $95,240 - $122,828	17,572 New	17,572 $121,000
Q1 2018 May 11, 2018	SELL	$4.66 - $7.08 $21,827 - $33,162	-4,684 Closed	0 $0
Q4 2017 Feb 09, 2018	SELL	$3.73 - $6.37 $634 - $1,082	-170 Reduced 3.5%	4,684 $21,000
Q3 2017 Nov 15, 2017	BUY	$5.28 - $6.88 $25,629 - $33,395	4,854	4,854 $30,000

Others Institutions Holding OCUL

# of Institutions

156

Shares Held

139M

Call Options Held

86.4K

Put Options Held

263K

View Full List

About OCULAR THERAPEUTIX, INC

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $844M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

More about OCUL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account

Group One Trading, L.P. Ocular Therapeutix, Inc Transaction History